Equity Overview
Price & Market Data
Price: $0.053
Daily Change: +$0.0018 / 3.40%
Range: $0.0452 - $0.0545
Market Cap: $2,890,026
Volume: 2,583,517
Performance Metrics
1 Week: 31.71%
1 Month: -60.00%
3 Months: -83.54%
6 Months: -85.17%
1 Year: -92.06%
YTD: -86.29%
Company Details
Employees: 18
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a novel and patented topical formulation candidate for the treatment of acute Peyronie's disease. The company offers men's health products, including vacuum erection devices, penile injections, PreBoost, VenoSeal, and urinary tract infection tests for the treatment of erectile dysfunction. Petros Pharmaceuticals, Inc. is based in New York, New York.